From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

We need to diversify our HIV workforce with new roles that align with the health and well-being ... scientist with clinical ...

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...

Any new HIV prevention method is not meant to sit on the shelf but to be used by the people who need it to protect themselves ...

“We are talking about sex and drugs—two topics that people call taboo,” said Brigitte Quenum, UNAIDS Regional Team Lead for ...

The CDC did not break out most data for county or region, but for New York State in 2023, there were 12,393 cases of all ...

Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained ...

Although sexually transmitted infections are still at an epidemic level in the US, scientists at the US Centers for Disease ...

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, linking these discriminatory policies to delays in effective HIV treatment ...